Overview
ISO 11608-1:2022/Amd 1:2026 is the first amendment to ISO 11608-1:2022, focusing on needle-based injection systems (NIS) for medical use. Developed by the International Organization for Standardization (ISO), this amendment refines requirements and test methods that ensure the safety, accuracy, and reliability of needle-based injection devices. The standard addresses key criteria for primary functionality, performance testing, and product lifecycle evaluation, reinforcing quality benchmarks essential for medical device manufacturers and stakeholders in the healthcare sector.
Key Topics
-
Primary Function Identification
The amendment mandates thorough assessment of design specifications for NIS, with a minimum requirement to include dose-delivery functions based on dose accuracy.
-
Test Methodology
Updated guidance is provided for measuring NIS primary functions, emphasizing robust calibration, repeatability, and reproducibility. Gauge R&R (Repeatability and Reproducibility) thresholds are set to enhance the reliability of test apparatus for both standard and destructive testing methods.
-
Lifecycle and Stability Testing
The amendment strengthens lifecycle evaluation by specifying test conditions and safety factors for NIS service life, shelf life, and in-use performance. Life-cycle testing ensures devices meet performance criteria after simulated extended use.
-
Risk Assessment and Verification
Enhanced focus is placed on risk assessment in identifying essential performance versus primary function. Verification includes extensive testing of primary functions in both normal and stressed/challenge conditions through the product’s lifecycle.
Applications
The requirements and guidance in ISO 11608-1:2022/Amd 1:2026 play a pivotal role in:
-
Design and Development
Medical device developers use the standard to guide the safe design and specification of needle-based injection systems, ensuring all critical functions are considered from the outset.
-
Quality and Compliance Testing
Manufacturers apply these test methods to demonstrate compliance with international regulations, supporting efficient product approvals and minimizing the risk of recalls.
-
Performance Verification
The specified test criteria and procedures help verify dose accuracy, functional stability, and reliability throughout the intended shelf life and in-use conditions of injection systems.
-
Risk Management
The standard supports risk-based approaches to product development and testing, assisting companies in identifying and mitigating potential sources of harm associated with NIS use.
Related Standards
Professionals working with ISO 11608-1:2022/Amd 1:2026 may also reference:
-
ISO 11608 Series
Additional parts of ISO 11608 cover various aspects of needle-based injection systems, such as component compatibility and specific safety features.
-
IEC/ISO Directives
Guidance on the development and maintenance of international standards, providing foundational practices for conformity and technical decision-making.
-
CEN/TC 205 Standards
Documents from the European Committee for Standardization covering non-active medical devices, often harmonized with ISO standards.
-
Risk Management Standards
Standards such as ISO 14971 (Application of risk management to medical devices) complement ISO 11608-1 by providing a framework for risk analysis and control throughout the device lifecycle.
For device developers, manufacturers, regulators, and quality professionals, adherence to ISO 11608-1:2022/Amd 1:2026 ensures that needle-based injection systems are objectively assessed for performance and safety, supporting global market access and patient safety. For more details, visit the official ISO website.
Open preview (PDF)Needle-based injection systems for medical use — Requirements and test methods — Part 1: Needle-based injection systems — Amendment 1